Ausgabe 2/2016
Inhalt (19 Artikel)
Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na+/K+-ATPase and cell survival
Chia-Chi Liu, Rachel Teh, Christine A. Mozar, Robert C. Baxter, Helge H. Rasmussen
Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer
Lars Jønson, Lise B. Ahlborn, Ane Y. Steffensen, Malene Djursby, Bent Ejlertsen, Susanne Timshel, Finn C. Nielsen, Anne-Marie Gerdes, Thomas V. O. Hansen
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach
Anton Safonov, Shiyi Wang, Cary P. Gross, Divyansh Agarwal, Giampaolo Bianchini, Lajos Pusztai, Christos Hatzis
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
Jennifer L. Dine, Ciara C. O’Sullivan, Donna Voeller, Yoshimi E. Greer, Kathryn J. Chavez, Catherine M. Conway, Sarah Sinclair, Brandon Stone, Laleh Amiri-Kordestani, Anand S. Merchant, Stephen M. Hewitt, Seth M. Steinberg, Sandra M. Swain, Stanley Lipkowitz
Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA
Francisco Quiles, Mireia Menéndez, Eva Tornero, Jesús del Valle, Àlex Teulé, Sarai Palanca, Angel Izquierdo, Carolina Gómez, Olga Campos, Raül Santamaria, Joan Brunet, Gabriel Capellá, Lídia Feliubadaló, Conxi Lázaro
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro
Johanna M. Tuomela, Jouko A. Sandholm, Mika Kaakinen, Katherine L. Hayden, Kirsi-Maria Haapasaari, Arja Jukkola-Vuorinen, Joonas H. Kauppila, Petri P. Lehenkari, Kevin W. Harris, David E. Graves, Katri S. Selander
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results
Anna G. Sorace, C. Chad Quarles, Jennifer G. Whisenant, Ariella B. Hanker, J. Oliver McIntyre, Violeta M. Sanchez, Thomas E. Yankeelov
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines
Ana Barac, Filipa Lynce, Karen L. Smith, Mihriye Mete, Nawar M. Shara, Federico M. Asch, Madeline P. Nardacci, Lynette Wray, Pia Herbolsheimer, Raquel A. Nunes, Sandra M. Swain, Robert Warren, Beth N. Peshkin, Claudine Isaacs
A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer
Joanne L. Blum, Anthony Gonçalves, Noa Efrat, Marc Debled, Pierfranco Conte, Paul D. Richards, Donald Richards, Pilar Lardelli, Antonio Nieto, Martin Cullell-Young, Suzette Delaloge
Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling
Walter M. Gregory, Christopher J. Twelves, Richard Bell, Stephen W. Smye, Dena R. Howard, Robert E. Coleman, David A. Cameron
Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis
Fei Cui, Duoguang Wu, Wenjian Wang, Xiaotian He, Minghui Wang
Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting
Terry Ng, Sasha Mazzarello, Zhou Wang, Brian Hutton, George Dranitsaris, Lisa Vandermeer, Stephanie Smith, Mark Clemons
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival
H. Frydenberg, I. Thune, T. Lofterød, E. S. Mortensen, A. E. Eggen, T. Risberg, E. A. Wist, V. G. Flote, A-S Furberg, T. Wilsgaard, L. A. Akslen, A. McTiernan
Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium
Edward A. Ruiz-Narváez, Stephen A. Haddad, Kathryn L. Lunetta, Song Yao, Jeannette T. Bensen, Lara E. Sucheston-Campbell, Chi-Chen Hong, Christopher A. Haiman, Andrew F. Olshan, Christine B. Ambrosone, Julie R. Palmer
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Pal Moller, Henry T. Lynch, Susan L. Neuhausen, Leigha Senter, Rochelle Demsky, William D. Foulkes, Charis Eng, Beth Karlan, Nadine Tung, Christian F. Singer, Ping Sun, Jan Lubinski, Steven A. Narod
A two-stage approach to genetic risk assessment in primary care
Swati Biswas, Philamer Atienza, Jonathan Chipman, Amanda L. Blackford, Banu Arun, Kevin Hughes, Giovanni Parmigiani
Adolescent intake of animal fat and red meat in relation to premenopausal mammographic density
Kimberly A. Bertrand, Rosemarie A. Burian, A. Heather Eliassen, Walter C. Willett, Rulla M. Tamimi
Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence
Joel M. Brothers, Kelley M. Kidwell, Richard K. J. Brown, N. Lynn Henry
Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study
Jeffrey S. Ross, Laurie M. Gay, Sahar Nozad, Kai Wang, Siraj M. Ali, Ann Boguniewicz, Depinder Khaira, Adrienne Johnson, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Vincent A. Miller, Philip J. Stephens